Luxury Fashion
The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More
Global Lung Cancer Market Research Report 2023
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Lung Cancer Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Surgery
1.2.3 Chemotherapy
1.2.4 Radiotherapy
1.2.5 Photodynamic Therapy
1.2.6 Laser Therapy
1.3 Market by Application
1.3.1 Global Lung Cancer Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospital & Clinics
1.3.3 Cancer Research Centers
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Lung Cancer Market Perspective (2017-2028)
2.2 Lung Cancer Growth Trends by Region
2.2.1 Lung Cancer Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Lung Cancer Historic Market Size by Region (2017-2022)
2.2.3 Lung Cancer Forecasted Market Size by Region (2023-2028)
2.3 Lung Cancer Market Dynamics
2.3.1 Lung Cancer Industry Trends
2.3.2 Lung Cancer Market Drivers
2.3.3 Lung Cancer Market Challenges
2.3.4 Lung Cancer Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Lung Cancer Players by Revenue
3.1.1 Global Top Lung Cancer Players by Revenue (2017-2022)
3.1.2 Global Lung Cancer Revenue Market Share by Players (2017-2022)
3.2 Global Lung Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Lung Cancer Revenue
3.4 Global Lung Cancer Market Concentration Ratio
3.4.1 Global Lung Cancer Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Lung Cancer Revenue in 2021
3.5 Lung Cancer Key Players Head office and Area Served
3.6 Key Players Lung Cancer Product Solution and Service
3.7 Date of Enter into Lung Cancer Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Lung Cancer Breakdown Data by Type
4.1 Global Lung Cancer Historic Market Size by Type (2017-2022)
4.2 Global Lung Cancer Forecasted Market Size by Type (2023-2028)
5 Lung Cancer Breakdown Data by Application
5.1 Global Lung Cancer Historic Market Size by Application (2017-2022)
5.2 Global Lung Cancer Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Lung Cancer Market Size (2017-2028)
6.2 North America Lung Cancer Market Size by Country (2017-2022)
6.3 North America Lung Cancer Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Lung Cancer Market Size (2017-2028)
7.2 Europe Lung Cancer Market Size by Country (2017-2022)
7.3 Europe Lung Cancer Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Lung Cancer Market Size (2017-2028)
8.2 Asia-Pacific Lung Cancer Market Size by Country (2017-2022)
8.3 Asia-Pacific Lung Cancer Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Lung Cancer Market Size (2017-2028)
9.2 Latin America Lung Cancer Market Size by Country (2017-2022)
9.3 Latin America Lung Cancer Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Lung Cancer Market Size (2017-2028)
10.2 Middle East & Africa Lung Cancer Market Size by Country (2017-2022)
10.3 Middle East & Africa Lung Cancer Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Detail
11.1.2 Roche Business Overview
11.1.3 Roche Lung Cancer Introduction
11.1.4 Roche Revenue in Lung Cancer Business (2017-2022)
11.1.5 Roche Recent Development
11.2 Novartis
11.2.1 Novartis Company Detail
11.2.2 Novartis Business Overview
11.2.3 Novartis Lung Cancer Introduction
11.2.4 Novartis Revenue in Lung Cancer Business (2017-2022)
11.2.5 Novartis Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Detail
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Lung Cancer Introduction
11.3.4 Pfizer Revenue in Lung Cancer Business (2017-2022)
11.3.5 Pfizer Recent Development
11.4 Merck
11.4.1 Merck Company Detail
11.4.2 Merck Business Overview
11.4.3 Merck Lung Cancer Introduction
11.4.4 Merck Revenue in Lung Cancer Business (2017-2022)
11.4.5 Merck Recent Development
11.5 Bristol-Myers Squibb
11.5.1 Bristol-Myers Squibb Company Detail
11.5.2 Bristol-Myers Squibb Business Overview
11.5.3 Bristol-Myers Squibb Lung Cancer Introduction
11.5.4 Bristol-Myers Squibb Revenue in Lung Cancer Business (2017-2022)
11.5.5 Bristol-Myers Squibb Recent Development
11.6 Eli Lilly And Company
11.6.1 Eli Lilly And Company Company Detail
11.6.2 Eli Lilly And Company Business Overview
11.6.3 Eli Lilly And Company Lung Cancer Introduction
11.6.4 Eli Lilly And Company Revenue in Lung Cancer Business (2017-2022)
11.6.5 Eli Lilly And Company Recent Development
11.7 Sanof
11.7.1 Sanof Company Detail
11.7.2 Sanof Business Overview
11.7.3 Sanof Lung Cancer Introduction
11.7.4 Sanof Revenue in Lung Cancer Business (2017-2022)
11.7.5 Sanof Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Lung Cancer Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Surgery
Table 3. Key Players of Chemotherapy
Table 4. Key Players of Radiotherapy
Table 5. Key Players of Photodynamic Therapy
Table 6. Key Players of Laser Therapy
Table 7. Global Lung Cancer Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Lung Cancer Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 9. Global Lung Cancer Market Size by Region (2017-2022) & (US$ Million)
Table 10. Global Lung Cancer Market Share by Region (2017-2022)
Table 11. Global Lung Cancer Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 12. Global Lung Cancer Market Share by Region (2023-2028)
Table 13. Lung Cancer Market Trends
Table 14. Lung Cancer Market Drivers
Table 15. Lung Cancer Market Challenges
Table 16. Lung Cancer Market Restraints
Table 17. Global Lung Cancer Revenue by Players (2017-2022) & (US$ Million)
Table 18. Global Lung Cancer Market Share by Players (2017-2022)
Table 19. Global Top Lung Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Cancer as of 2021)
Table 20. Ranking of Global Top Lung Cancer Companies by Revenue (US$ Million) in 2021
Table 21. Global 5 Largest Players Market Share by Lung Cancer Revenue (CR5 and HHI) & (2017-2022)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Lung Cancer Product Solution and Service
Table 24. Date of Enter into Lung Cancer Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Lung Cancer Market Size by Type (2017-2022) & (US$ Million)
Table 27. Global Lung Cancer Revenue Market Share by Type (2017-2022)
Table 28. Global Lung Cancer Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 29. Global Lung Cancer Revenue Market Share by Type (2023-2028)
Table 30. Global Lung Cancer Market Size by Application (2017-2022) & (US$ Million)
Table 31. Global Lung Cancer Revenue Market Share by Application (2017-2022)
Table 32. Global Lung Cancer Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 33. Global Lung Cancer Revenue Market Share by Application (2023-2028)
Table 34. North America Lung Cancer Market Size by Country (2017-2022) & (US$ Million)
Table 35. North America Lung Cancer Market Size by Country (2023-2028) & (US$ Million)
Table 36. Europe Lung Cancer Market Size by Country (2017-2022) & (US$ Million)
Table 37. Europe Lung Cancer Market Size by Country (2023-2028) & (US$ Million)
Table 38. Asia-Pacific Lung Cancer Market Size by Region (2017-2022) & (US$ Million)
Table 39. Asia-Pacific Lung Cancer Market Size by Region (2023-2028) & (US$ Million)
Table 40. Latin America Lung Cancer Market Size by Country (2017-2022) & (US$ Million)
Table 41. Latin America Lung Cancer Market Size by Country (2023-2028) & (US$ Million)
Table 42. Middle East & Africa Lung Cancer Market Size by Country (2017-2022) & (US$ Million)
Table 43. Middle East & Africa Lung Cancer Market Size by Country (2023-2028) & (US$ Million)
Table 44. Roche Company Detail
Table 45. Roche Business Overview
Table 46. Roche Lung Cancer Product
Table 47. Roche Revenue in Lung Cancer Business (2017-2022) & (US$ Million)
Table 48. Roche Recent Development
Table 49. Novartis Company Detail
Table 50. Novartis Business Overview
Table 51. Novartis Lung Cancer Product
Table 52. Novartis Revenue in Lung Cancer Business (2017-2022) & (US$ Million)
Table 53. Novartis Recent Development
Table 54. Pfizer Company Detail
Table 55. Pfizer Business Overview
Table 56. Pfizer Lung Cancer Product
Table 57. Pfizer Revenue in Lung Cancer Business (2017-2022) & (US$ Million)
Table 58. Pfizer Recent Development
Table 59. Merck Company Detail
Table 60. Merck Business Overview
Table 61. Merck Lung Cancer Product
Table 62. Merck Revenue in Lung Cancer Business (2017-2022) & (US$ Million)
Table 63. Merck Recent Development
Table 64. Bristol-Myers Squibb Company Detail
Table 65. Bristol-Myers Squibb Business Overview
Table 66. Bristol-Myers Squibb Lung Cancer Product
Table 67. Bristol-Myers Squibb Revenue in Lung Cancer Business (2017-2022) & (US$ Million)
Table 68. Bristol-Myers Squibb Recent Development
Table 69. Eli Lilly And Company Company Detail
Table 70. Eli Lilly And Company Business Overview
Table 71. Eli Lilly And Company Lung Cancer Product
Table 72. Eli Lilly And Company Revenue in Lung Cancer Business (2017-2022) & (US$ Million)
Table 73. Eli Lilly And Company Recent Development
Table 74. Sanof Company Detail
Table 75. Sanof Business Overview
Table 76. Sanof Lung Cancer Product
Table 77. Sanof Revenue in Lung Cancer Business (2017-2022) & (US$ Million)
Table 78. Sanof Recent Development
Table 79. Research Programs/Design for This Report
Table 80. Key Data Information from Secondary Sources
Table 81. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Lung Cancer Market Share by Type: 2021 VS 2028
Figure 2. Surgery Features
Figure 3. Chemotherapy Features
Figure 4. Radiotherapy Features
Figure 5. Photodynamic Therapy Features
Figure 6. Laser Therapy Features
Figure 7. Global Lung Cancer Market Share by Application in 2021 & 2028
Figure 8. Hospital & Clinics Case Studies
Figure 9. Cancer Research Centers Case Studies
Figure 10. Others Case Studies
Figure 11. Lung Cancer Report Years Considered
Figure 12. Global Lung Cancer Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 13. Global Lung Cancer Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Lung Cancer Market Share by Region: 2021 VS 2028
Figure 15. Global Lung Cancer Market Share by Players in 2021
Figure 16. Global Top Lung Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Cancer as of 2021)
Figure 17. The Top 10 and 5 Players Market Share by Lung Cancer Revenue in 2021
Figure 18. North America Lung Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. North America Lung Cancer Market Share by Country (2017-2028)
Figure 20. United States Lung Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Canada Lung Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Lung Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Lung Cancer Market Share by Country (2017-2028)
Figure 24. Germany Lung Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. France Lung Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. U.K. Lung Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Italy Lung Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Russia Lung Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Nordic Countries Lung Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Asia-Pacific Lung Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Asia-Pacific Lung Cancer Market Share by Region (2017-2028)
Figure 32. China Lung Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Japan Lung Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. South Korea Lung Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Southeast Asia Lung Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. India Lung Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Australia Lung Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Latin America Lung Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Latin America Lung Cancer Market Share by Country (2017-2028)
Figure 40. Mexico Lung Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Brazil Lung Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Middle East & Africa Lung Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Middle East & Africa Lung Cancer Market Share by Country (2017-2028)
Figure 44. Turkey Lung Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Saudi Arabia Lung Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Roche Revenue Growth Rate in Lung Cancer Business (2017-2022)
Figure 47. Novartis Revenue Growth Rate in Lung Cancer Business (2017-2022)
Figure 48. Pfizer Revenue Growth Rate in Lung Cancer Business (2017-2022)
Figure 49. Merck Revenue Growth Rate in Lung Cancer Business (2017-2022)
Figure 50. Bristol-Myers Squibb Revenue Growth Rate in Lung Cancer Business (2017-2022)
Figure 51. Eli Lilly And Company Revenue Growth Rate in Lung Cancer Business (2017-2022)
Figure 52. Sanof Revenue Growth Rate in Lung Cancer Business (2017-2022)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Roche Novartis Pfizer Merck Bristol-Myers Squibb Eli Lilly And Company Sanof